Live feed
Filing
SC 13G
SC 13G0001193125-19-040928·Adamas Pharmaceuticals Inc
Schedule 13G ownership disclosure
ADAMAS PHARMACEUTICALS INC
Security class unavailable · CUSIP: 00548A106
Event date: 2018-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.9100%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-19-040928
- Form type
- SC 13G
- Filer
- Adamas Pharmaceuticals Inc
- CIK
- CIK 1328143
- Filed
- Feb 14, 2019
- Reporting period
- Dec 31, 2018
- Description
- Schedule 13G beneficial ownership